Latest KFF Health News Stories
As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr Vaccine
Recent leaps in medical research have lent urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus that has been linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.
¡No te perfores los dientes! Cómo acabar con los malos consejos dentales en TikTok
Estilizar los dientes ha sido una práctica común durante siglos en todo el mundo. Pero las redes sociales, sobre todo TikTok, han dado vida a tendencias como las gemas dentales.
Centene Gave Thousands to Georgia Leaders’ Campaigns While Facing Medicaid Overbilling Questions
Centene is trying to settle accusations of Medicaid pharmaceutical overcharging in Georgia, and the St. Louis-based company has been giving thousands of dollars to the campaigns of the state attorney general and the governor.
Campaigning Ramps Up as South Dakota Voters Decide on Medicaid Expansion
A broad coalition of Medicaid expansion supporters faces off against a smaller group of opponents as early voting begins on a constitutional amendment that would increase coverage under South Dakota’s program.
Don’t Drill Your Own Teeth! And Quashing Other Rotten Dental Advice on TikTok
TikTok videos extol doing your own cosmetic dentistry like gluing gems to your front teeth or filing down your teeth. The trouble is social media rarely shows the mistakes or the pain.
Comienzan a estar disponibles audífonos de venta libre desde $199
Los audífonos de venta libre cuestan menos en parte porque no incluyen los servicios de un experto para una evaluación auditiva, ajuste y afinación del dispositivo. En cambio, los nuevos dispositivos deben ser configurados por los propios consumidores.
Say What? Hearing Aids Available Over-the-Counter for as Low as $199, and Without a Prescription
The cheaper over-the-counter aids are for adults with mild to moderate hearing loss — a market of tens of millions of people, many of whom have until now been priced out because prescription devices can cost thousands of dollars.
Listen: Why Childbirth Is So Dangerous for Many Young Teens
KHN senior correspondent Sarah Varney talks with NPR’s “Weekend Edition Sunday” about how the abortion bans proliferating in many U.S. states will affect teenage birth rates and the physical risks that trend poses for girls.
After Congress Fails to Add Dental Coverage, Medicare Weighs Limited Benefit Expansion
Medicare can pay for some dental care if it is medically necessary to safely treat another covered medical condition, and federal officials have asked for suggestions on whether that list of conditions should be expanded.
Lawsuit by KHN Prompts Government to Release Medicare Advantage Audits
The lawsuit was filed three years ago to learn about vast overcharges by the popular health plans that are detailed in audits the government refused to release to the public.
Will Covid Spike Again This Fall? 6 Tips to Help You Stay Safe
Recent research suggests that the covid virus is mutating to better dodge people’s immune defenses. It could soon evade monoclonal antibodies used to treat covid. KHN examines what public health officials believe is on the horizon and how best to fight the disease.
5 Things to Know About Colorado’s Psychedelics Ballot Initiative
The good, the bad, and the unknown about the Centennial State’s proposal to decriminalize and regulate magic mushrooms and plant-based psychedelics.
You may have seen the ads that promise weight loss and better health — phone apps, rings, and other devices — by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
KHN’s ‘What the Health?’: Finally Fixing the ‘Family Glitch’
The Biden administration has decided to try to fix the so-called “family glitch” in the Affordable Care Act without an act of Congress. The provision has prevented workers’ families from getting subsidized coverage if an employer offer is unaffordable. Meanwhile, Medicare’s open enrollment period begins Oct. 15, and private Medicare Advantage plans are poised to cover more than half of Medicare’s 65 million enrollees. Margot Sanger-Katz of The New York Times, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read.
La nueva generación de medicamentos para la pérdida de peso es prometedora, pero tiene un precio
Algunos pacientes, según los especialistas en medicina de la obesidad, experimentan una disminución de la presión arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sueño gracias a estos nuevos tratamientos.
As Giant Hospitals Get Bigger, an Independent Doctor Feels the Pinch
Independent medical practices keep closing as doctors join behemoth hospital groups or leave the field. Research suggests that’s bad news for patients. Studies repeatedly conclude that consolidation in the health care industry is driving up costs while showing no clear evidence of improved care.
‘An Arm and a Leg’: Checking Up on California’s DIY Insulin Project
California put up $100 million to produce its own insulin. How did this plan come to be, and what might stand in the state’s way?
Baby, That Bill Is High: Private Equity ‘Gambit’ Squeezes Excessive ER Charges From Routine Births
Hospitals, boosted by private equity-backed staffing companies, have embraced a new idea: the obstetrics emergency department. Often, it is just a triage room in the labor-and-delivery area, but it bills like the main emergency department.
New Generation of Weight Loss Medications Offer Promise — But at a Price
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
Índice de masa corporal: una medida errónea del peso que afecta el tratamiento de la obesidad
Los tratamientos actuales para la obesidad y los trastornos alimentarios, y sus costos, muchas veces se basan en esta medida que no está amparada en la ciencia.
